ATE308539T1 - Prozess zur herstellung des anti-migräne wirkstoffs eletriptan - Google Patents

Prozess zur herstellung des anti-migräne wirkstoffs eletriptan

Info

Publication number
ATE308539T1
ATE308539T1 AT01271106T AT01271106T ATE308539T1 AT E308539 T1 ATE308539 T1 AT E308539T1 AT 01271106 T AT01271106 T AT 01271106T AT 01271106 T AT01271106 T AT 01271106T AT E308539 T1 ATE308539 T1 AT E308539T1
Authority
AT
Austria
Prior art keywords
eletriptan
producing
migraine
active
migraine active
Prior art date
Application number
AT01271106T
Other languages
English (en)
Inventor
Ronald Ogilvie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE308539T1 publication Critical patent/ATE308539T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT01271106T 2000-12-20 2001-12-06 Prozess zur herstellung des anti-migräne wirkstoffs eletriptan ATE308539T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0031094.6A GB0031094D0 (en) 2000-12-20 2000-12-20 New Process
PCT/IB2001/002338 WO2002050063A1 (en) 2000-12-20 2001-12-06 New process

Publications (1)

Publication Number Publication Date
ATE308539T1 true ATE308539T1 (de) 2005-11-15

Family

ID=9905487

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271106T ATE308539T1 (de) 2000-12-20 2001-12-06 Prozess zur herstellung des anti-migräne wirkstoffs eletriptan

Country Status (20)

Country Link
EP (1) EP1373254B1 (de)
JP (1) JP2004516290A (de)
KR (1) KR20030061448A (de)
CN (1) CN1199969C (de)
AR (2) AR035406A1 (de)
AT (1) ATE308539T1 (de)
AU (1) AU2002218440A1 (de)
BR (1) BR0116324A (de)
CA (1) CA2432138C (de)
CZ (1) CZ20031640A3 (de)
DE (1) DE60114668T2 (de)
ES (1) ES2249386T3 (de)
GB (1) GB0031094D0 (de)
HU (1) HUP0302465A2 (de)
IL (1) IL155706A0 (de)
MX (1) MXPA03005569A (de)
PL (1) PL362716A1 (de)
RU (1) RU2256660C2 (de)
WO (1) WO2002050063A1 (de)
ZA (1) ZA200303446B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927296B2 (en) 2003-07-23 2005-08-09 Pfizer Inc. Process
EP2093224A1 (de) * 2007-05-01 2009-08-26 Plus Chemicals B.V. Verfahren zur Herstellung von Eletriptan-Hydrobromid der Form Beta
IT1393700B1 (it) * 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011024039A1 (en) * 2009-08-25 2011-03-03 Ramesh Babu Potluri Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives
WO2011089614A1 (en) 2010-01-19 2011-07-28 Sms Pharmaceuticals Limited PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM
WO2012004811A1 (en) * 2010-07-06 2012-01-12 Ind-Swift Laboratories Limited Process for the preparation of 5-substsituted indole derivative
JP2019502761A (ja) 2016-01-21 2019-01-31 ラボラトリオス レヴィ エセエレ ((r)−3−[(−1−メチルピロリジン−2−イル)メチル]−5−(2−フェニルスルホニルエチル)−1h−インドールを作製する方法
CN112440631B (zh) * 2020-11-02 2022-09-13 长城汽车股份有限公司 一种调节胎压装置、方法、系统以及车辆

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225055B1 (en) * 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds

Also Published As

Publication number Publication date
GB0031094D0 (en) 2001-01-31
PL362716A1 (en) 2004-11-02
AR043016A2 (es) 2005-07-13
AR035406A1 (es) 2004-05-26
MXPA03005569A (es) 2003-10-06
WO2002050063A1 (en) 2002-06-27
EP1373254B1 (de) 2005-11-02
CN1487932A (zh) 2004-04-07
EP1373254A1 (de) 2004-01-02
BR0116324A (pt) 2003-10-14
DE60114668D1 (de) 2005-12-08
CZ20031640A3 (cs) 2004-08-18
ZA200303446B (en) 2004-07-05
JP2004516290A (ja) 2004-06-03
CN1199969C (zh) 2005-05-04
CA2432138A1 (en) 2002-06-27
KR20030061448A (ko) 2003-07-18
CA2432138C (en) 2007-05-08
ES2249386T3 (es) 2006-04-01
HUP0302465A2 (hu) 2003-12-29
RU2256660C2 (ru) 2005-07-20
AU2002218440A1 (en) 2002-07-01
DE60114668T2 (de) 2006-07-20
IL155706A0 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
DE50102299D1 (de) Verfahren zur herstellung des anticholinergikums tiotropiumbromid
ATE263354T1 (de) Vorrichtung zur herstellung von kontaktkörpern
DE60137039D1 (de) Verschiebung von verschlüssen zur herstellung von windeln
DE60134410D1 (de) Methode zur herstellung funktioneller proteindomänen
DE69940056D1 (de) Vorrichtung zur herstellung softeismassen
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
MXPA03002813A (es) Compuestos utiles en el tratamiento de enfermedades inflamatorias.
FI20011621A0 (fi) Menetelmä sitalopraamin valmistamiseksi
DE60041391D1 (de) Vorrichtung zur herstellung von spiralförmiger gewickelten elektrodenanordnung
ATE287328T1 (de) Giessform zur herstellung von kontaktlinsen
DE69902488D1 (de) Vorrichtung zur herstellung kastenloser formen
ATE278691T1 (de) Verbesserter prozess zur herstellung von carbapenemen
DE19781711T1 (de) Vorrichtung zur Herstellung hexagonalen Wassers
DE60100858D1 (de) Prozess zur herstellung der kristallinen form i von cabergolin
DE60018173D1 (de) Giessform zur herstellung eines kühlelementes
DE69918781D1 (de) Die verwendung von tee-polyphenolen zur herstellung von anti-chlamydia mitteln
ATE372118T1 (de) Die verwendung von rosiglitazon zur behandlung von psychiatrischen erkrankungen.
ATE308539T1 (de) Prozess zur herstellung des anti-migräne wirkstoffs eletriptan
FR2818979B1 (fr) Procede de preparation d'imidaclopride
DE60101124D1 (de) Verfahren zur Herstellung von Sulfinaten
ATE250611T1 (de) Pyranoindole zur glaukombehandlung
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
DE60104789D1 (de) Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden
DE60114482D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluoraceton
DE50207427D1 (de) Vorrichtung zur Herstellung palettierfähiger Lagen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties